Literature DB >> 24852503

Involuntary movements due to vitamin B12 deficiency.

Aaron de Souza, M W Moloi.   

Abstract

Deficiency of vitamin B12 produces protean effects on the nervous system, most commonly neuropathy, myelopathy, cognitive and behavioural symptoms, and optic atrophy. Involuntary movements comprise a relatively rare manifestation of this readily treatable disorder. Both adults and infants deficient in vitamin B12 may present with chorea, tremor, myoclonus, Parkinsonism, dystonia, or a combination of these, which may precede diagnosis or become apparent only a few days after parenteral replacement therapy has begun. The pathogenesis of these movement disorders shows interesting parallels to certain neurodegenerative conditions. The clinical syndrome responds well to vitamin B12 supplementation in most cases, and an early diagnosis is essential to reverse the haematological and neurological dysfunction characteristic of this disorder. In this article, we elucidate the association of vitamin B12 deficiency with movement disorders in adults and in infants, discuss the pathogenesis of this association, review previously reported cases, and present a young adult male with severe generalized chorea that showed a salutary response to vitamin B12 supplementation.

Entities:  

Keywords:  Chorea,; Cobalamin,; Megaloblastic anaemia; Movement disorders,; Myoclonus,; Tremor,; Vitamin B12,

Mesh:

Substances:

Year:  2014        PMID: 24852503     DOI: 10.1179/1743132814Y.0000000396

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  3 in total

1.  Post-Treatment Movement Disorder in a Child with Late-onset Cobalamin Deficiency.

Authors:  Ala Fadilah; Peter S Baxter; Ptolemaios G Sarrigiannis; Soma Sengupta; Mark J Sharrard; Santosh R Mordekar
Journal:  Mov Disord Clin Pract       Date:  2021-12-27

Review 2.  Movement disorders and neuropathies: overlaps and mimics in clinical practice.

Authors:  Francesco Gentile; Alessandro Bertini; Alberto Priori; Tommaso Bocci
Journal:  J Neurol       Date:  2022-06-03       Impact factor: 6.682

Review 3.  Treatable Hyperkinetic Movement Disorders Not to Be Missed.

Authors:  Aurélie Méneret; Béatrice Garcin; Solène Frismand; Annie Lannuzel; Louise-Laure Mariani; Emmanuel Roze
Journal:  Front Neurol       Date:  2021-12-01       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.